Cases 11 - 20 of 122
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv00120
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv01042
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Cause Of Action: 35 U.S.C. § 271
SUN PHARMACEUTICAL INDUSTRIES LIMITED v. NOVARTIS PHARMACEUTICALS CORP. et al
as 2:2019cv00276
Defendant:
NOVARTIS AG and NOVARTIS PHARMACEUTICALS CORP.
Plaintiff:
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Cause Of Action: 28 U.S.C. § 1331
Alcon Vision, LLC. v. Allied Vision Group, Inc. et al
as 1:2018cv02486
Defendant:
National Lens LLC and Allied Vision Group, Inc.
Plaintiff:
Alcon Laboratories, Inc. and Alcon Vision, LLC.
Counter Defendant:
Novartis AG
Cause Of Action: 15 U.S.C. § 1114 Trademark Infringement
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00867
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Breckenridge Pharmaceutical, Inc.
as 1:2017cv00420
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Breckenridge Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v Mylan Pharmaceuticals Inc.
as 1:2017cv00054
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals USA, Inc.
as 1:2017cv00393
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv00389
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Pharmaceuticals Inc.
Counter_defendant:
Novartis AG and Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Alembic Pharmaceuticals Limited v. Novartis AG et al
as 1:2017cv00292
Plaintiff:
Alembic Pharmaceuticals Limited
Defendant:
Novartis AG and Mitsubishi Tanabe Pharma Corporation
Cause Of Action: 35 U.S.C. § 1
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
